VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Oct 16, 2024 7:55pm

90 Views

Post# 36269169

Hannah Crane BSE2024 👀 remember 4.0 Europe ❤ 📍🚀

Very interesting last weekend to see Hannah Crane at BSE2024 and see everyone who liked the post,We are excited to be attending the British Society Of Echocardiography Conference in Edinburgh on October 11th and 12th!

The BEST automation and analysis of the PLANET GEN3EHO On the Ascend website https://ascendcv.com/

Hugh MacNaught likes this

We are excited to be attending the British Society Of Echocardiography Conference in Edinburgh on October 11th and 12th! Looking forward to reconnecting with colleagues, learning about the latest advancements in echo practice, and sharing insights on Ventripoint's VMS+ and why adding this solution will benefit their patients in daily practice. BSEcho2024 Ventripoint